Bioactive constituents of Terminalia ferdinandiana Exell: A pharmacognistic approach towards the prevention and treatment of yersiniosis

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Henry Wright, Mitchell
Jean Arnold, Megan Sarah
Aldosary, Huda
Sirdaarta, Joseph
Carlson Greene, Anthony
Edwin Cock, Ian
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2016
Size
File type(s)
Location
Abstract

Introduction: Yersinia enterocolitica is a facultatively anaerobic gram negativebacterium which contaminates meat products causing the acute gastrointestinal disease yersiniosis. Terminalia ferdinandiana (Kakadu plum, gubinge) is an Australian fruit with an extremely high antioxidant capacity. It was used therapeutically by the first Australians and has documentedantiseptic properties against an extensive panel of bacteria. Despite this, it has not been tested for the ability to inhibit the growth of Y. enterocolitica. Methods: T. ferdinandiana fruit and leaf extracts were extracted by maceration and the extracts were investigated by disc diffusion assay for growth inhibitory activity against a clinical strain of Y. enterocolitica. The MIC values of the extractswere determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. The most potent extracts were investigated using non-targeted GC-MS analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Solvent extractions of T. ferdinandiana leaf and fruit displayed good growth inhibitory activity in the disc diffusion assay against Y. enterocolitica. The methanolic T. ferdinandiana leaf and fruitextracts, as well as the fruit ethyl acetate extract, were particularly potent growth inhibitors, with MIC values of 372, 123 and 285 µg/mL respectively. The aqueous and ethyl acetate leaf extracts alsodisplayed good growth inhibitory activity against Y. enterocolitica, albeit with higher MIC values (588 and 1100 µg/mL respectively). All other extracts were either lowefficacy, or completely devoid of growth inhibitory activity. All T. ferdinandiana leaf and fruit extracts were either nontoxic (LC50 values <1000 µg/mL) or of low toxicity in the Artemia franciscana bioassay. Non-biased GC-MS phytochemical analysis of the methanolic extractsputatively identified and highlighted several compounds that may contribute to the ability of these extracts to inhibit the growth of Y. enterocolitica. Conclusions: The lack of toxicity and the potent growth inhibitory bioactivity of the T. ferdinandiana fruit and leaf methanolic extracts against Y. Enterocolitica indicates their potential as medicinal agents in the treatment and prevention of yersiniosis.

Journal Title

Pharmacognosy Communications

Conference Title
Book Title
Edition
Volume

6

Issue

3

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© The Author(s) 2016. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International (CC BY-NC-ND 4.0) License (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.

Item Access Status
Note
Access the data
Related item(s)
Subject

Plant Biology

Pharmacology and Pharmaceutical Sciences

Persistent link to this record
Citation

Henry Wright, M; Jean Arnold, MS; Aldosary, H; Sirdaarta, J; Carlson Greene, A; Edwin Cock, I, Bioactive constituents of Terminalia ferdinandiana Exell: A pharmacognistic approach towards the prevention and treatment of yersiniosis, Pharmacognosy Communications, 6 (3), pp. 152-163

Collections